 The Stage I research program now includes development of targeted Alzheimers Disease therapy using bioelectronics Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation research program Key objective is identification of electrical frequencies with a neuroprotection potency Novel approach could emerge as alternative Alzheimers Disease therapy to current, ineffective pharmaceuticals Global therapy market is huge, estimated to reach 13.3 billion in 2023 The Stage I research program now includes development of targeted Alzheimers Disease therapy using bioelectronics Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation research program Key objective is identification of electrical frequencies with a neuroprotection potency Novel approach could emerge as alternative Alzheimers Disease therapy to current, ineffective pharmaceuticals Global therapy market is huge, estimated to reach 13.3 billion in 2023 